The representativeness of eligible patients in type 2 diabetes trials: a case study using GIST 2.0.
The population representativeness of a clinical study is influenced by how real-world patients qualify for the study. We analyze the representativeness of eligible patients for multiple type 2 diabetes trials and the relationship between representativeness and other trial characteristics.
Author(s): Sen, Anando, Goldstein, Andrew, Chakrabarti, Shreya, Shang, Ning, Kang, Tian, Yaman, Anil, Ryan, Patrick B, Weng, Chunhua
DOI: 10.1093/jamia/ocx091